Letter to Shareholders emailed in the last hour. Dear

New Post Public Reply Private Reply Replies (2) Message Board
Natural Treasures
2,399
Letter to Shareholders emailed in the last hour.

Dear Verb Shareholders,

As you know, our Board recently approved a series of initiatives to address what we believed could be the illegal naked short selling of our shares. We announced the engagement of ShareIntel who began their investigative work several weeks ago. We also engaged other professionals, including Tom Ronk, the principal behind BuyIns.net. This is the team engaged by several other listed companies who also believe they are being victimized by illegal short selling activities.

This week we received our first comprehensive reports from the investigators, and the information appears to represent significant naked short selling of our shares, evidenced by ‘fails to deliver’ and ‘fails to receive’ imbalance data, among other data. Notably, this data appears to be conspicuously absent from the officially published short selling reports.

The effect of this activity is to create enormous numbers of phantom shares for sale. This places continuous pressure on the share price by disrupting the normal laws of supply and demand, which are the dynamics that should be the primary drivers of share price.

Our investigators’ reports also provide information identifying the firms at which this activity is taking place. We have been advised by the investigators that these are the same firms who have been identified by other public companies currently investigating illegal short selling activity.

It seems that their mission is to hold the share price below $1 so that our company is delisted from Nasdaq. If they succeed, they will never have to cover their legitimate short sale positions and the evidence of their illicit short sale activity will become more difficult to expose. As you know, we have a deadline of May 8 to trade above $1 during the preceding 10 trading days in order to avoid delisting.

Our Nasdaq listing is extremely valuable as the charters of most larger institutional investors prohibit investments in non-exchange listed companies and we currently have many large institutional holders. In addition, after a delisting we would lose access to our shelf registration making it more difficult to raise capital. To lose our Nasdaq listing because of the wrongful acts of these individuals would compound their illicit activities and the resultant damage to our company and our shareholders.

The investigative work is ongoing as we continue to analyze data and compile evidence. All of this information is being shared with counsel who will advise us on the appropriate next steps.

To help improve the share price and restore it to the levels before the naked short sellers manipulated our stock, we have put several initiatives into place. These include:
1. the launch of MARKET.live, a world class livestream shopping platform with enormous value creation capabilities;
2. we implemented a series of cost-cutting initiatives across the entire organization to reduce reliance on the capital markets, including reductions in the salaries of all senior executives, including myself, as well as all of our board members. For example, I have consistently deferred a large portion of my total compensation, and last fall, cut the cash portion of my compensation by 25% as part of a larger plan to reduce operating expenses;
3. we have reduced our burn by more than 65%, and over the past 3.5 months we have added $16 million in cash to our balance sheet opportunistically;
4. last month, we finished the pay-off of our $6 million senior secured debt;
5. last month, we cancelled our $50 million equity line of credit;
6. last fall, we engaged Alantra, an international strategic advisory firm to advise our board on market opportunities some of which are currently under consideration by our board;
7. to reward our shareholders and as part of a larger plan to combat the naked short selling identified by our investigators, our board is actively considering the issuance of a special dividend;

However, there are things that only you the shareholders can do to help ensure the company retains our Nasdaq listing. Those things include authorizing a share consolidation, which is really just a soft way of saying reverse split. I believe many of you know that I am not a fan of reverse stock splits unless employed to uplist to a national exchange. However, it is a powerful tool to combat the short sellers who are bent on seeing our company, your company, delisted to hide their manipulation of our stock. Many experts agree that the smaller the public float, the more difficult it is to short stock. We’ve seen a number of companies adopt this strategy as part of their plan to address illegal naked short selling.

It is my sincere hope that the initiatives discussed above that we have placed in motion, and on which we have worked very hard, will be sufficient to move the share price above the $1 Nasdaq threshold. But we must recognize that we are in a war battling those who appear willing to employ illegal activities to hold us down. Accordingly, we will take all steps necessary to preserve your rights to implement those solutions the majority of you determine to be necessary to protect and preserve your interests.


The Board and I recognize that these are challenging times. But we are fully committed to doing what is right, preserving what we believe is a company with exceptional products and potential, and to ensuring that we maintain the level of transparency that all investors deserve. We will continue to defend the company and our shareholders against the machinations of illegal short sellers and grow the company into what we know it can be.

Thank you for your consideration and commitment to Verb.

Verb Technology Company, Inc.

Rory J. Cutaia, Chairman & CEO
1

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 8

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Boost for Inseego as George Mulhern Joins Board

Updated Category News Views 140

Inseego Welcomes George Mulhern to Its Board of Directors Inseego Corp. (Nasdaq: INSG) is thrilled to announce the appointment of George Mulhern, a distinguished leader in the wireless technology sector, to its Board of Directors. With a profound background in developing and steering wireless tech companies, Mr. Mulhern has most recently held the position of Senior Vice...

Continue Reading
Economic Outlook Raises Concerns of Inflation Under Trump

Updated Category News Views 128

Increased Economic Concerns with Trump's Return Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits. Survey Findings on Inflation and Economic Policies A survey conducted by a group of economists indicates a majority foresee higher inflation and...

Continue Reading
Join the Class Action Against Rocket Pharmaceuticals Today

Updated Category News Views 134

Join the Class Action Against Rocket Pharmaceuticals Investors are being called to participate in a class action lawsuit concerning Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). This lawsuit is aimed at recovering losses incurred by shareholders due to alleged securities fraud that impacted the company's financial standing during a specified timeframe. Understanding the...

Continue Reading
Nipocalimab Receives Priority Review from U.S. FDA for gMG

Updated Category News Views 297

Nipocalimab Secures U.S. FDA Priority Review Status Johnson & Johnson (NYSE: JNJ) has exciting news regarding its investigational drug, Nipocalimab. The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for Nisocalimab as a treatment for generalized myasthenia gravis (gMG) in patients with specific autoantibodies. This important milestone...

Continue Reading
Navigating the Canadian Multifamily Landscape: Supply and Demand

Updated Category News Views 89

Understanding Canada's Multifamily Market Trends In recent times, the Canadian multifamily housing market has exhibited some intriguing trends, particularly concerning rent growth and vacancy rates. As highlighted in the latest report from Yardi Canada, the market showcases a scenario where rent growth is slowing, while vacancies remain low. This situation reflects the...

Continue Reading